The Journal of Immunology, Vol 156, Issue 2 435-441, Copyright © 1996 by American Association of Immunologists

ARTICLES

An alternative splice variant of human IL-4, IL-4 delta 2, inhibits IL- 4-stimulated T cell proliferation

SP Atamas, J Choi, VV Yurovsky and B White
Department of Medicine, University of Maryland at Baltimore, USA.

Alternative splicing of mRNA can generate protein isoforms that are preferentially expressed in different tissues or during different states of cell differentiation or activation. Protein isoforms may have different functions. In this study, we cloned, expressed, and tested functional effects of a naturally occurring splice variant of human IL- 4, called IL-4 delta 2. In IL-4 delta 2, the second exon of IL-4 is omitted by alternative splicing, with exons 1, 3, and 4 joined in an open reading frame. We found that IL-4 delta 2 RNA is expressed in the PBMC of all donors tested, usually in lower amounts than IL-4 RNA. In contrast, IL-4 delta 2 RNA is expressed in much higher levels than IL-4 RNA in thymocytes and bronchoalveolar lavage cells, suggesting tissue specificity of expression. IL-4 delta 2 cDNA was expressed in yeast. Recombinant human (rh) IL-4 delta 2 was partially purified and found to be glycosylated, with a protein core of 13 to 15 kDa. Unlike rhIL-4, rhIL-4 delta 2 did not act as a costimulator for T cell proliferation. However, rhIL-4 delta 2 inhibited the ability of rhIL-4 to act as a T cell costimulator. Inhibition was independent of glycosylation and was not mediated by toxicity. Iodinated IL-4 delta 2 was found to bind specifically to human PBMC and tumor lines known to express IL-4 receptors. Excess unlabeled IL-4 inhibited cellular binding of labeled IL-4 delta 2. Thus, rhIL-4 delta 2 is a naturally occurring splice variant of IL-4 that is preferentially expressed in the thymus and airways and inhibits function of complete IL-4. The balance between IL- 4 and IL-4 delta 2 may be important in the regulation of IL-4 effects.

This article has been cited by other articles:

				S. G. Rhodes, J. Sawyer, A. O. Whelan, G. S. Dean, M. Coad, K. J. Ewer, A. S. Waldvogel, A. Zakher, D. J. Clifford, R. G. Hewinson, et al. Is Interleukin-4{delta}3 Splice Variant Expression in Bovine Tuberculosis a Marker of Protective Immunity? Infect. Immun., June 1, 2007; 75(6): 3006 - 3013. [Abstract] [Full Text] [PDF]

				K. Dheda, J.-S. Chang, R. A. M. Breen, L. U. Kim, J. A. Haddock, J. F. Huggett, M. A. Johnson, G. A. W. Rook, and A. Zumla In Vivo and In Vitro Studies of a Novel Cytokine, Interleukin 4{delta}2, in Pulmonary Tuberculosis Am. J. Respir. Crit. Care Med., August 15, 2005; 172(4): 501 - 508. [Abstract] [Full Text] [PDF]

				S. Wu, R. Gessner, T. Taube, A. von Stackelberg, G. Henze, and K. Seeger Expression of Interleukin-10 Splicing Variants Is a Positive Prognostic Feature in Relapsed Childhood Acute Lymphoblastic Leukemia J. Clin. Oncol., May 1, 2005; 23(13): 3038 - 3042. [Abstract] [Full Text] [PDF]

				B. Orsini, B. Ottanelli, A. Amedei, E. Surrenti, M. Capanni, G. Del Prete, A. Amorosi, S. Milani, M. M. D'Elios, and C. Surrenti Helicobacter pylori cag Pathogenicity Island Is Associated with Reduced Expression of Interleukin-4 (IL-4) mRNA and Modulation of the IL-4{delta}2 mRNA Isoform in Human Gastric Mucosa Infect. Immun., November 1, 2003; 71(11): 6664 - 6667. [Abstract] [Full Text] [PDF]

				E. Ledru, M. Fevrier, H. Lecoeur, S. Garcia, S. Boullier, and M.-L. Gougeon A nonsecreted variant of interleukin-4 is associated with apoptosis: implication for the T helper-2 polarization in HIV infection Blood, April 15, 2003; 101(8): 3102 - 3105. [Abstract] [Full Text] [PDF]

				Y. Yang, L. Li, G. W. Wong, S. A. Krilis, M. S. Madhusudhan, A. Sali, and R. L. Stevens RasGRP4, a New Mast Cell-restricted Ras Guanine Nucleotide-releasing Protein with Calcium- and Diacylglycerol-binding Motifs. IDENTIFICATION OF DEFECTIVE VARIANTS OF THIS SIGNALING PROTEIN IN ASTHMA, MASTOCYTOSIS, AND MAST CELL LEUKEMIA PATIENTS AND DEMONSTRATION OF THE IMPORTANCE OF RasGRP4 IN MAST CELL DEVELOPMENT AND FUNCTION J. Biol. Chem., July 5, 2002; 277(28): 25756 - 25774. [Abstract] [Full Text] [PDF]

				M. P. Bihl, K. Heinimann, J. J. Rudiger, O. Eickelberg, A. P. Perruchoud, M. Tamm, and M. Roth Identification of a Novel IL-6 Isoform Binding to the Endogenous IL-6 Receptor Am. J. Respir. Cell Mol. Biol., July 1, 2002; 27(1): 48 - 56. [Abstract] [Full Text] [PDF]

				S. P. Atamas, I. G. Luzina, H. Dai, S. G. Wilt, and B. White Synergy Between CD40 Ligation and IL-4 on Fibroblast Proliferation Involves IL-4 Receptor Signaling J. Immunol., February 1, 2002; 168(3): 1139 - 1145. [Abstract] [Full Text] [PDF]

				G. T. SEAH, P. S. GAO, J. M. HOPKIN, and G. A. W. ROOK Interleukin-4 and Its Alternatively Spliced Variant (IL-4delta 2) in Patients with Atopic Asthma Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 1016 - 1018. [Abstract] [Full Text] [PDF]

				S. P. Atamas and B. White Interleukin 4 in Systemic Sclerosis: Not Just an Increase Clin. Vaccine Immunol., September 1, 1999; 6(5): 658 - 659. [Full Text] [PDF]

				L. I. Sakkas, C. Tourtellotte, S. Berney, A. R. Myers, and C. D. Platsoucas Increased Levels of Alternatively Spliced Interleukin 4 (IL-4delta 2) Transcripts in Peripheral Blood Mononuclear Cells from Patients with Systemic Sclerosis Clin. Vaccine Immunol., September 1, 1999; 6(5): 660 - 664. [Abstract] [Full Text] [PDF]

				Z. Jaffar, K. Roberts, A. Pandit, P. Linsley, R. Djukanovic, and S. Holgate B7 Costimulation Is Required for IL-5 and IL-13 Secretion by Bronchial Biopsy Tissue of Atopic Asthmatic Subjects in Response to Allergen Stimulation Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 153 - 162. [Abstract] [Full Text]

				M. HUMBERT, C. J. CORRIGAN, P. KIMMITT, S. J. TILL, A. BARRY KAY, and S. R. DURHAM Relationship between IL-4 and IL-5 mRNA Expression and Disease Severity in Atopic Asthma Am. J. Respir. Crit. Care Med., September 1, 1997; 156(3): 704 - 708. [Abstract] [Full Text] [PDF]